Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
301 Leser
Artikel bewerten:
(1)

Florence Healthcare: TruLab Integration to Florence Streamlines Biospecimen Data Management for Clinical Sites

ATLANTA, GA / ACCESSWIRE / February 7, 2024 / TruLab, a leading provider of sample management solutions, and Florence Healthcare, the leading site enablement platform used by over 18,000 connected research sites in 55+ countries, announce a technology partnership that provides a single solution to capture and store biospecimen and other protocol data into one source.

Florence + TruLab

Florence + TruLab

TruLab's advanced data capture platform, combined with Florence's eBinders electronic investigator site file (eISF) system, will allow sites using both platforms to seamlessly exchange content between the two, providing sponsors with access to quality, real-time source data, while reducing site burden and streamlining clinical site workflows.

This integrated solution will enable same-day centralized monitoring by CRAs and sponsors in eBinders through Florence's SiteLink®. Instead of waiting days to weeks for data to be manually entered in the EDC, remote monitors can now see biospecimen data as the visit is being conducted.

Importantly, the TruLab Florence eBinders integration addresses one of the biggest problems plaguing the industry today, which is that an estimated 20% of biospecimens are lost or unusable due to a lack of visibility at the clinical site. In addition, sample testing is often placed on hold while queries on discrepant biospecimen data are being investigated and resolved, leading to clinical trial delays. This partnership will provide a single eSource for high-quality biospecimen data, accelerating the clinical trial process for sponsors and alleviating the burden on sites around query resolution.

This integrated platform will:

  • Reduce lab queries by over 90%
  • Eliminate handwriting on paper forms, logbooks, and draw sheets
  • Eliminate manual data entry and transcription errors into web portals
  • Reduce duplicate records that have to be maintained and source data verified
  • Proactively send alerts and notifications when a deviation or anomaly occurs
  • Enable centralized monitoring of protocol deviations, anomalies, and other exceptions such as missed and unscheduled visits, missed shipments, skipped aliquots and more

"Our technology partnership with TruLab expands the access sponsors and CROs have to clinical trial content at the study site through our SiteLink solution, while maintaining our mission to enable every site to do their best work through best-in-class technology and integrations," said Ryan Jones, CEO of Florence.

"We are thrilled to partner with Florence to provide sponsors with an even more robust and integrated solution for their sample management needs," said Scott Ogle, CEO of TruLab. "By integrating our technology with Florence's eBinders, we are able to offer a solution that eliminates handwriting and paper at clinical sites, while improving data integrity."

About TruLab
TruLab, Inc. is a sample management software company that provides advanced point-of-collection tracking solutions for the clinical research industry. Their technology is designed to help clinicians, labs and pharmaceutical sponsors manage their clinical samples more effectively, while ensuring consistent compliance with study protocols.

About Florence Healthcare
Florence Healthcare is the leading provider of the Site Enablement Platform, committed to accelerating cures by better connecting sponsors, CROs, and research sites. With over 18,000 connected research sites on its platform in 55 countries, the company streamlines the clinical trial process, enabling seamless collaboration and efficient management of clinical research workflows.

Contact Information

Blake Adams
SVP Marketing, Florence
blake.adams@florencehc.com

David Chung
press@trulab.com

SOURCE: Florence Healthcare

.

View the original press release on newswire.com.

© 2024 ACCESSWIRE
Sondersituation: Vervielfachungschance bei diesen Goldaktien

Der Goldpreis haussiert und schwingt sich von Hoch zu Hoch. Getrieben von geopolitischen Unsicherheiten sowie der Aussicht auf eine lockere Geldpolitik der FED gehen Experten aktuell von weiter steigenden Notierungen bis sogar in den Bereich von 3.000 US-Dollar je Unze Gold aus.

Im Schatten des Basispreises notieren Goldproduzenten aus der zweiten Reihe sowie Explorationsunternehmen noch weit weg von ihren historischen Höchstständen entfernt und bieten dadurch erhebliches Aufholpotential.

In diesem kostenlosen Report geben wir Ihnen Favoriten an die Hand, die aufgrund von Sondersituation die Chance auf eine Kursvervielfachung besitzen.

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von dem weiter steigenden Kurs des Edelmetalls.

Sichern Sie sich jetzt Ihren kostenfreien Report.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.